Histamine H3-receptor ligands and their therapeutic applications
US8076329B2 · kind B2 · utility
2Cited by
13References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 25, 2006 |
| Grant date | Dec 13, 2011 |
| Priority date | — |
| Expiry date | Jul 4, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present patent application concerns compounds of formula (I) with R1 and R2 taken together with the nitrogen atom to which they are attached, form a mono or bicyclic saturated nitrogen-containing ring; their preparation and their use as a H3 receptor ligand for treating e.g. CNS disorders like Alzheimer's disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.